Population cost-effectiveness of the Triple P parenting programme for the treatment of conduct disorder: an economic modelling study

European Child & Adolescent Psychiatry
F SampaioCathrine Mihalopoulos

Abstract

Parenting programmes are the recommended treatments of conduct disorders (CD) in children, but little is known about their longer term cost-effectiveness. This study aimed to evaluate the population cost-effectiveness of one of the most researched evidence-based parenting programmes, the Triple P-Positive Parenting Programme, delivered in a group and individual format, for the treatment of CD in children. A population-based multiple cohort decision analytic model was developed to estimate the cost per disability-adjusted life year (DALY) averted of Triple P compared with a 'no intervention' scenario, using a health sector perspective. The model targeted a cohort of 5-9-year-old children with CD in Australia currently seeking treatment, and followed them until they reached adulthood (i.e., 18 years). Multivariate probabilistic and univariate sensitivity analyses were conducted to incorporate uncertainty in the model parameters. Triple P was cost-effective compared to no intervention at a threshold of AU$50,000 per DALY averted when delivered in a group format [incremental cost-effectiveness ratio (ICER) = $1013 per DALY averted; 95% uncertainty interval (UI) 471-1956] and in an individual format (ICER = $20,498 per DALY averted;...Continue Reading

References

Jul 28, 2001·BMJ : British Medical Journal·S ScottB Maughan
May 30, 2003·Population Health Metrics·Jan J BarendregtChristopher JL Murray
Jul 22, 2005·Journal of Child Psychology and Psychiatry, and Allied Disciplines·David M FergussonElizabeth M Ridder
Jul 22, 2005·Journal of Child Psychology and Psychiatry, and Allied Disciplines·David M FergussonElizabeth M Ridder
Jan 13, 2006·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Sandra M Reyno, Patrick J McGrath
Jun 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Renee RomeoStephen Scott
Apr 28, 2007·The Australian and New Zealand Journal of Psychiatry·Cathrine MihalopoulosRob Carter
Jul 5, 2007·Journal of Abnormal Child Psychology·Matthew R SandersAlina Morawska
Apr 2, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Anthony H HarrisEmily Walkom
Mar 27, 2009·Public Health Reports·Scott D GrosseMary Chamie
Dec 1, 2008·Expert Review of Pharmacoeconomics & Outcomes Research·Rob CarterCathrine Mihalopoulos
Oct 15, 2013·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Holly E ErskineJames G Scott
Jan 23, 2014·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Holly E ErskineJames G Scott
Sep 25, 2016·Journal of the American Academy of Child and Adolescent Psychiatry·Holly E ErskineJames G Scott
Aug 24, 2017·The Australian and New Zealand Journal of Psychiatry·Jordana K BayerRonald M Rapee
Nov 1, 2003·Child and Adolescent Mental Health·Alicia J Martin, Matthew R Sanders

❮ Previous
Next ❯

Citations

Oct 9, 2018·Journal of Paediatrics and Child Health·James G ScottStephen Stathis
Oct 21, 2019·Administration and Policy in Mental Health·Camilla NystrandInna Feldman
Sep 17, 2020·Administration and Policy in Mental Health·Megan M Hare, Paulo A Graziano
Jun 30, 2019·Nature Reviews. Disease Primers·Graeme FairchildStephane A De Brito
Jul 17, 2021·Journal of Community Psychology·Tina H BonnettKaren R Schouten
Aug 18, 2021·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Elisa RissanenEila Kankaanpää

❮ Previous
Next ❯

Software Mentioned

Ersatz
NSMHWB
Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.